Maxine B Yonker from Emerald Hills, CA

Dhea Composition And Method
view source
US Patent:

20060234992, Oct 19, 2006
Filed:

Mar 21, 2006
Appl. No.:

11/387111
Inventors:

Jagdish Parasrampuria - Bedminster NJ, US
Maxine Yonker - Emerald Hills CA, US
Kenneth Schwartz - San Mateo CA, US
Marc Gurwith - Los Altos CA, US
International Classification:

A61K 31/57
US Classification:

514177000
Abstract:

Disclosed are improved pharmaceutical formulations comprising dehydroepiandrosterone (DHEA), enriched in selected polymorphic forms, for therapeutic applications. In one embodiment, the formulation comprises, in solid form, DHEA, at least 85% of which is present as a single polymorph selected from the form I polymorph or the form II polymorph, and at least one pharmaceutical excipient. Methods for making and using such compositions are also disclosed.

Dhea Composition And Method
view source
US Patent:

7045513, May 16, 2006
Filed:

Mar 16, 2000
Appl. No.:

09/526802
Inventors:

Jagdish Parasrampuria - Bridgewater NJ, US
Maxine B. Yonker - Emerald Hills CA, US
Kenneth E. Schwartz - San Mateo CA, US
Marc J. Gurwith - Los Altos CA, US
Assignee:

Genelabs Technologies, Inc. - Redwood City CA
International Classification:

A61K 31/56
US Classification:

514170, 514169, 514177, 514178, 514180
Abstract:

Disclosed are improved pharmaceutical formulations comprising dehydroepiandrosterone (DHEA), enriched in selected polymorphic forms, for therapeutic applications. In one embodiment, the formulation comprises, in solid form, DHEA, at least 85% of which is present as a single polymorph selected from the form I polymorph or the form II polymorph, and at least one pharmaceutical excipient. Methods for making and using such compositions are also disclosed.

Maxine B Yonker